EXI3:XETRA:XETRA-iShares Dow Jones Industrial Average UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 374.15

Change

+0.05 (+0.01)%

Market Cap

USD 0.30B

Volume

376.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.09 (+0.17%)

USD 484.40B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.03 (+0.19%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.04 (-0.15%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.03 (+0.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.06 (+0.25%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+1.18 (+0.83%)

USD 98.29B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.05%)

USD 98.25B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.04 (+0.09%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.34 (-0.43%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.01 (-0.02%)

USD 79.79B

ETFs Containing EXI3:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.22% 66% D+ 66% D+
Dividend Return 0.68% 22% F 13% F
Total Return 10.90% 69% C- 68% D+
Trailing 12 Months  
Capital Gain 17.38% 66% D+ 67% D+
Dividend Return 0.72% 19% F 12% F
Total Return 18.10% 68% D+ 68% D+
Trailing 5 Years  
Capital Gain 52.53% 73% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.53% 73% C 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 10.77% 74% C 72% C
Dividend Return 11.12% 75% C 72% C
Total Return 0.35% 33% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 11.56% 53% F 63% D
Risk Adjusted Return 96.12% 94% A 95% A
Market Capitalization 0.30B 54% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.